$1.38 Billion is the total value of Boxer Capital, LLC's 49 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MRTX | MIRATI THERAPEUTICS INC | $133,659,000 | -24.4% | 1,715,560 | 0.0% | 9.69% | -36.2% | |
ODT | ODONATE THERAPEUTICS INC | $87,549,000 | -29.1% | 3,363,377 | 0.0% | 6.35% | -40.2% | |
DBVT | DBV TECHNOLOGIES S Asponsored adr | $45,580,000 | +4.6% | 5,300,000 | 0.0% | 3.30% | -11.7% | |
MDCO | MEDICINES CO | $37,500,000 | +37.1% | 750,000 | 0.0% | 2.72% | +15.6% | |
ESPR | ESPERION THERAPEUTICS INC NE | $35,744,000 | -21.2% | 975,000 | 0.0% | 2.59% | -33.5% | |
PTCT | PTC THERAPEUTICS INC | $33,820,000 | -24.8% | 1,000,000 | 0.0% | 2.45% | -36.6% | |
ARGX | ARGENX SEsponsored adr | $22,792,000 | -19.5% | 200,000 | 0.0% | 1.65% | -32.1% | |
BCEL | ATRECA INC | $21,219,000 | -35.0% | 1,733,583 | 0.0% | 1.54% | -45.2% | |
MIST | MILESTONE PHARMACEUTICALS IN | $20,556,000 | -31.3% | 1,102,194 | 0.0% | 1.49% | -42.1% | |
WVE | WAVE LIFE SCIENCES LTD | $20,530,000 | -21.3% | 1,000,000 | 0.0% | 1.49% | -33.6% | |
FOLD | AMICUS THERAPEUTICS INC | $18,647,000 | -35.7% | 2,325,000 | 0.0% | 1.35% | -45.8% | |
RCKT | ROCKET PHARMACEUTICALS INC | $17,079,000 | -22.3% | 1,466,051 | 0.0% | 1.24% | -34.5% | |
PRVL | PREVAIL THERAPEUTICS INC | $13,792,000 | -7.0% | 1,123,105 | 0.0% | 1.00% | -21.6% | |
KURA | KURA ONCOLOGY INC | $12,815,000 | -23.0% | 844,789 | 0.0% | 0.93% | -35.0% | |
GBT | GLOBAL BLOOD THERAPEUTICS IN | $12,130,000 | -7.8% | 250,000 | 0.0% | 0.88% | -22.3% | |
IMMUNOMEDICS INCcall | $7,956,000 | -4.4% | 600,000 | 0.0% | 0.58% | -19.3% | ||
IDYA | IDEAYA BIOSCIENCES INC | $6,878,000 | -9.6% | 764,252 | 0.0% | 0.50% | -23.7% | |
MTNB | MATINAS BIOPHARMA HLDGS INC | $6,424,000 | -26.4% | 10,188,312 | 0.0% | 0.47% | -37.9% | |
CBAY | CYMABAY THERAPEUTICS INC | $6,400,000 | -28.5% | 1,250,000 | 0.0% | 0.46% | -39.7% | |
MEIP | MEI PHARMA INC | $4,894,000 | -32.8% | 2,913,091 | 0.0% | 0.36% | -43.3% | |
KNSA | KINIKSA PHARMACEUTICALS LTD | $2,473,000 | -37.1% | 290,577 | 0.0% | 0.18% | -47.0% | |
KALV | KALVISTA PHARMACEUTICALS INC | $2,320,000 | -47.6% | 200,000 | 0.0% | 0.17% | -55.9% | |
CLRB | CELLECTAR BIOSCIENCES INC | $1,840,000 | -8.3% | 920,000 | 0.0% | 0.13% | -22.7% | |
NVUS | NOVUS THERAPEUTICS INC | $201,000 | -38.7% | 324,383 | 0.0% | 0.02% | -46.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MIRATI THERAPEUTICS INC | 32 | Q3 2023 | 55.2% |
BEIGENE LTD | 31 | Q3 2023 | 15.6% |
KURA ONCOLOGY INC. | 24 | Q3 2021 | 4.7% |
ROCKET PHARMACEUTICALS INC | 23 | Q3 2023 | 5.4% |
DBV TECHNOLOGIES S A | 23 | Q3 2023 | 3.9% |
MEI PHARMA INC | 21 | Q2 2023 | 1.4% |
SYNDAX PHARMACEUTICALS INC | 20 | Q3 2021 | 3.1% |
GOSSAMER BIO INC | 19 | Q3 2023 | 4.7% |
ODONATE THERAPEUTICS INC | 18 | Q1 2022 | 12.5% |
ESPERION THERAPEUTICS INC NE | 18 | Q2 2021 | 11.0% |
View Boxer Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
IDEAYA Biosciences, Inc. | February 14, 2023 | 2,202,812 | 4.6% |
Milestone Pharmaceuticals Inc. | February 14, 2023 | 698,861 | 2.0% |
SpringWorks Therapeutics, Inc. | September 19, 2022 | 3,421,541 | 5.7% |
iTeos Therapeutics, Inc. | May 11, 2022 | 2,154,058 | 6.1% |
Atreca, Inc. | February 14, 2022 | 2,202,333 | 7.2% |
Biomea Fusion, Inc. | February 14, 2022 | 1,188,405 | 4.1% |
Cabaletta Bio, Inc. | February 14, 2022 | 540,000 | 1.9% |
CymaBay Therapeutics, Inc. | February 14, 2022 | ? | ? |
DBV Technologies S.A. | February 14, 2022 | 1,067,299 | 1.9% |
Elevation Oncology, Inc. | February 14, 2022 | 872,780 | 3.8% |
View Boxer Capital, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G | 2024-04-22 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G | 2024-02-12 |
4 | 2024-02-08 |
SC 13D/A | 2024-02-08 |
4 | 2024-01-25 |
SC 13D/A | 2024-01-25 |
SC 13G | 2024-01-18 |
SC 13D/A | 2023-12-18 |
View Boxer Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.